Experimental cancer injection trial seeks to shrink tumors
NCT ID NCT06736379
Summary
This early-stage study is testing whether directly injecting an experimental treatment called VLPONC-01 into head and neck tumors is safe and can help shrink them. Researchers are enrolling 41 patients with advanced or surgically removable cancers to receive the injections, sometimes combined with an existing immunotherapy drug. The main goal is to check for side effects while also measuring how tumors respond to the treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Stanford University
RECRUITINGStanford, California, 34305, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.